Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ADMA Biologics Inc (NASDAQ:ADMA)

9.31
Delayed Data
As of 11:07am ET
 +0.058 / +0.63%
Today’s Change
7.51
Today|||52-Week Range
14.00
-16.67%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
AssetsCash----26.1M17.2M
 
 
 
Short Term Investment Cash-141.2K12.4M13.6M-9.0M
 
 
 
 
 
Cash & Short Term Investments87.8K12.5M29.1M21.9M
 
 
 
 
 
 
ReceivablesReceivables0.0039.1K0.00384.0K
 
 
 
 
InventoriesInventories1.1M1.3M1.7M1.7M
 
 
 
 
 
 
Current AssetsPrepaid Expenses59.2K107.8K298.7K143.6K
 
 
 
 
 
Current Assets1.3M13.9M31.1M24.1M
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross1.5M1.6M1.8M4.1M
 
 
 
 
 
Depreciation-686.2K-825.4K-1.0M-1.3M
 
 
 
 
 
Other Assets433.7K376.0K162.2K298.8K
 
 
 
 
 
Total Assets2.9M15.6M32.0M27.2M
 
 
 
 
 
 
LiabilitiesAccounts Payable1.3M1.1M2.7M1.8M
 
 
 
 
 
Short Term Debt460.6K11.6K12.7K13.8K
 
 
 
 
 
Accrued Expenses537.7K747.1K860.1K2.3M
 
 
 
 
 
Other Current Liabilities537.7K747.1K935.7K2.4M
 
 
 
 
 
Other Liabilities2.3M1.8M3.7M4.2M
 
 
 
 
 
 
Total LiabilitiesLong Term Debt88.6K4.0M5.1M15.0M
 
 
 
 
 
Other Liabilities0.00229.3K0.00476.8K
 
 
 
Total Liabilities2.5M6.1M10.4M21.2M
 
 
 
 
 
 
EquityMinority Interest0.000.000.000.00--
Preferred Stock8.2K0.000.000.00
 
 
Common Equity377.6K9.4M21.6M6.0M
 
 
 
 
 
Total Shareholder Equity385.8K9.4M21.6M6.0M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding408.6K4.6M9.3M9.3M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.